Highlights
NASDAQ: VCEL       Vericel Corproation
Last Price Today's Change   Day's Range   Trading Volume
19.12   +0.14 (0.74%)  18.60 - 19.64  1,718,030

Overview

 
Avg Volume (4 weeks):533,768
4 Weeks Range:14.84 - 19.64
4 Weeks Price Volatility (%):
89.17%
52 Weeks Range:6.78 - 19.64
52 Weeks Price Volatility (%):
95.96%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company dedicated to the identification, development, and commercialization of innovative therapies that enable the body to repair and regenerate damaged tissues and organs to restore normal structure and function. Vericel has marketed products and the goal is to become the leader in cell therapy and regenerative medicine by developing, manufacturing and marketing best-in-class therapies for patients with significant unmet medical needs. The Company operates in one reportable segment: the research, product development, manufacture and distribution of patient-specific, expanded cellular therapies for use in the treatment of specific diseases.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

2010  3947  233  3092 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 AAPL 106.84-3.50 
 LK 1.38+1.38 
 KODK 12.11+1.41 
 ONTX 0.322+0.072 
 GE 6.88-0.17 
 SAVA 10.07+2.98 
 SQQQ 27.48+1.06 
 WFC 25.13+0.02 
 TSLA 442.15+18.72 
 RIG 1.06-0.05 
PARTNERS & BROKERS